-
Neuromyelitis optica (NMO) may be a unique central nervous system demyelinating disease with distinct clinical and MRI manifestations, as well as different immune and pathological characteristics as compared to multiple sclerosis (MS).
-
Aspirin plus extended-release dipyridamole and clopidogrel are both appropriate options to decrease disability from recurrent stroke; however, telmisartan does not lower risk of suffering a second stroke.
-
Statins may cause worsening symptoms in patients with myasthenia gravis.
-
Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.
-
-
Intravenous thrombolysis is safe and effective for the treatment of ischemic stroke in the time window of 3-4.5 hours after the onset of symptoms.
-
There is promising evidence that botulinum toxin type A provides analgesia in patients with painful focal neuropathy independent of its neuromuscular blocking action.
-
-
This study showed that intra-abdominal hypertension is associated with increased organ dysfunction and higher ICU mortality, and two commonly used methods for measuring intra-abdominal pressure have equivalent predictive capabilities.
-
In a prospective study of immunocompetent patients admitted to critical care units, CMV viremia showed a significant association with prolonged ICU stay and death.
